ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,829.56
-0.11%
Dow Jones
42,286.25
-0.03%
US Dollar vs MXN
20.45851
-0.77%
Brent Oil
79.385
-1.11%
Bitcoin
95,773.84
1.34%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Leap Therapeutics Inc (LPTX)

  7. Leap Therapeutics Inc (LPTX) Noticias

Leap Therapeutics Inc

Leap Therapeutics Inc (LPTX)

NASDAQ
3.08
-0.02
( -0.65% )
Actualizado: 10:22:12
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

LPTX Noticias

Solo noticias oficiales

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Octubre 2024
LPTX (-0.65%)

Form 8-K - Current report
Edgar (US Regulatory)
30 Septiembre 2024
LPTX (-0.65%)

Form 8-K - Current report
Edgar (US Regulatory)
12 Agosto 2024
LPTX (-0.65%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
12 Agosto 2024
LPTX (-0.65%)

Form 8-K - Current report
Edgar (US Regulatory)
08 Julio 2024
LPTX (-0.65%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
23 Mayo 2024
LPTX (-0.65%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
23 Mayo 2024
LPTX (-0.65%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Mayo 2024
LPTX (-0.65%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Mayo 2024
LPTX (-0.65%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
10 Mayo 2024
LPTX (-0.65%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
09 Mayo 2024
LPTX (-0.65%)

LPTX Discussion

Ver más
ANTADOG ANTADOG 1 día hace
nice volume comin' in, 3,22~~, ANT
👍️0
ANTADOG ANTADOG 6 días hace
added some more, only partial fill, ANT
👍️0
ANTADOG ANTADOG 1 semana hace
nice chart setup, solid 3,50 break gettin' closer, ANT
👍️0
ANTADOG ANTADOG 2 semanas hace
4's towards nxt update and jp conference almost a given, ANT
👍️0
ANTADOG ANTADOG 2 semanas hace
touchin' 3's again, so little vol needed, nxt update should be saweet imvho ANT
👍️0
ANTADOG ANTADOG 3 semanas hace
touched 3 again, small prelude of things to come, imosho ANT
👍️0
ANTADOG ANTADOG 4 semanas hace
hearin' some good things comin' our way, hmm, u got to pay to play, ANT
👍️0
ANTADOG ANTADOG 1 mes hace
Added 2,96~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,40~~ because they know... ANT
👍️0
ANTADOG ANTADOG 1 mes hace
accumulated a nice amount around 3 bucks, longterm, ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,35~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,33~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
Volume intact, ANT
👍️0
ANTADOG ANTADOG 1 mes hace
hooverin' above 3 bucks, ceo certainly gave them somethin' to think about, to be continued.... ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,33~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,24~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,19~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
mm in trouble lol, ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,12~~ ANT
👍️0
ANTADOG ANTADOG 1 mes hace
3,10 break is close, hmm, ANT
👍️0
ANTADOG ANTADOG 1 mes hace
added some 2,80's, likin' the chart, ANT
👍️0
glenn1919 glenn1919 1 mes hace
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
ANTADOG ANTADOG 2 meses hace
And some more 3,25's longterm, ANT
👍️0
ANTADOG ANTADOG 2 meses hace
added 3,70 ANT
👍️0
ANTADOG ANTADOG 2 meses hace
held first support, startin' to like this one more and more, gild support, fyi ANT
👍️0
ANTADOG ANTADOG 2 meses hace
added first support, ANT
👍️0
ANTADOG ANTADOG 3 meses hace
consistent buyin' often means deeper pockets like what they see or are about to find out, so they add while it's cheap, imo but we'll see soon, ANT
👍️0
ANTADOG ANTADOG 3 meses hace
puppy's goin' for a new 52wk high imo ANT
👍️0
ANTADOG ANTADOG 3 meses hace
because it's a double digitland stock, xcellent results will propel it imosho ANT
👍️0
joelawyer joelawyer 3 meses hace
Any clue what's driving this major upside move the last week?

👍️0
glenn1919 glenn1919 3 meses hace
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 meses hace
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 meses hace
LPTX under $3
👍️0
Monksdream Monksdream 6 meses hace
LPTX under $3
👍️0
Monksdream Monksdream 6 meses hace
LPTX under $2
👍️0
Monksdream Monksdream 8 meses hace
LPTX under $5
👍️0
glenn1919 glenn1919 9 meses hace
LPTX...................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 meses hace
LPTX 10Q due March 12
👍️0
glenn1919 glenn1919 1 año hace
LPTX.......................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 año hace
LPTX................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 año hace
LPTX new 52 week low
👍️0
Monksdream Monksdream 1 año hace
LPTX new 52 week low
👍️0
Slicky1315 Slicky1315 2 años hace
Wow..almost a year and no one posted anything!!
👍️0
VivaLasVegas VivaLasVegas 3 años hace
No one in their right mind gives 2 Sheets what some joke analyst gives for any price target

They are Shills
👍️0
stockguard stockguard 3 años hace
LPTX Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update Jan. 23
Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics (LPTX) to $6 from $5 and keeps an Overweight rating on the shares. Following the ASCO GI update for DKN-01, Leap hosted a conference call on Friday to walk through the data and lay out potential next steps, the analyst notes. When considering potential treatment effect, Catanzaro thinks the signal in DKK1-high patients looks even more compelling. Leap believes it could initiate a small randomized Phase II as part of the current IND that could generate data in 2023, while simultaneously engaging regulatory agencies on registrational strategies. Most notably, BeiGene's (BGNE) opt-in decision for Asian rights will almost certainly be a 2022 event, and the analyst continues to believe the ASCO GI update should make that a straightforward choice.
👍️0
Deano361 Deano361 3 años hace
yep, something big happening here.
👍️0
crudeoil24 crudeoil24 3 años hace
4.08 > hod.
👍️0
masterofdisaster masterofdisaster 3 años hace
I think I am going to double my position on Monday
👍️0
Deano361 Deano361 3 años hace
Yeah that was super strong after share offer . I think Beigene (sp?) may know this is real and we are a $10 acquisition target next year
👍️0
masterofdisaster masterofdisaster 3 años hace
The daily build up of short exempts on this momentum is driving the move. The cancer treatment results started the move. We shook off the share dump like it was nothing
👍️0

Su Consulta Reciente

NASDAQ
LPTX
Leap Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados